Match!

Molecular mechanisms of ezetimibe-induced attenuation of postprandial hypertriglyceridemia.

Published on Jan 1, 2010in Journal of Atherosclerosis and Thrombosis3.48
· DOI :10.5551/jat.4929
Jose C. Sandoval11
Estimated H-index: 11
(Osaka University),
Yumiko Nakagawa-Toyama16
Estimated H-index: 16
(Osaka University)
+ 13 AuthorsShizuya Yamashita59
Estimated H-index: 59
(Osaka University)
Abstract
Aim: Postprandial hypertriglyceridemia (PHTG) has been shown repeatedly to be associated with metabolic syndrome and atherosclerotic cardiovascular diseases. We have recently reported that ezetimibe inhibits PHTG in patients with type IIb hyperlipidemia. Ezetimibe was also reported to atten-uate PHTG in combination with low-dose statins in patients with obesity or metabolic syndrome. We reported CD36-deficient (CD36KO) mice as a new model for PHTG, in which the synthesis of chylomicron (CM) in the small intestines is enhanced. In the current study, we investigated the effect of ezetimibe on PHTG in this mouse model of metabolic syndrome.Methods: Wild-type (WT) mice fed a western diet, and CD36KO mice fed a normal chow diet, respectively, were treated for 3 weeks with and without ezetimibe, followed by an evaluation of triglyceride (TG) concentrations by enzymatic method and by high performance liquid chromatogra-phy (HPLC) as well as those of and apolipoprotein (Apo) B-48 in plasma and intestinal lymph after oral fat loading with olive oil. Intestinal mucosa was also harvested to evaluate the transcriptional regulation of the genes involved in the intestinal production of ApoB-containing lipoproteins.Results: Ezetimibe dramatically reduced PHTG in both WT and CD36KO mice. HPLC analysis of plasma showed that the decrease in TG content in CM and CM remnants-sized particles contributed to this suppression, suggesting that CM production in the small intestines might be reduced after ezetimibe treatment. Intestinal lymph was collected after oral fat loading in ezetimibe-treated and non-treated mice. Both TG content and ApoB-48 mass were decreased in ezetimibe-treated mice. The quantitative RT-PCR of intestinal mucosa showed down-regulation of the mRNA expression of FATP4 and ApoB in both groups along with FABP2, DGAT1, DGAT2 and SCD1 in WT mice at postprandial state after ezetimibe treatment.Conclusion: Ezetimibe alone reduces PHTG by blocking both the absorption of cholesterol and the intracellular trafficking and metabolism of long-chain fatty acids in enterocytes, resulting in the reduction of the formation of ApoB-48 which is necessary for the ApoB48-containing lipoprotein production in the small intestines.
  • References (28)
  • Citations (33)
References28
Newest
#1Daisaku MasudaH-Index: 17
#2Yumiko Nakagawa-Toyama (Osaka University)H-Index: 16
Last.Shizuya YamashitaH-Index: 59
view all 10 authors...
74 CitationsSource
#1Daisaku MasudaH-Index: 17
#2Ken-ichi HiranoH-Index: 38
Last.Shizuya YamashitaH-Index: 59
view all 18 authors...
76 CitationsSource
#1Xiong Su (WashU: Washington University in St. Louis)H-Index: 13
#2Nada A. Abumrad (WashU: Washington University in St. Louis)H-Index: 59
202 CitationsSource
#1William C. TaylorH-Index: 1
#2Nigel UnwinH-Index: 1
17.2k Citations
#1Gideon R. Hajer (UU: Utrecht University)H-Index: 8
Last.Frank L.J. Visseren (UU: Utrecht University)H-Index: 44
view all 4 authors...
38 CitationsSource
78 CitationsSource
#1Jacob J. FreibergH-Index: 15
Last.Børge G. NordestgaardH-Index: 119
view all 4 authors...
316 CitationsSource
#1Chi-Liang Eric Yen (UW: University of Wisconsin-Madison)H-Index: 12
#2Scot J. Stone (U of S: University of Saskatchewan)H-Index: 16
Last.Robert V. Farese (UCSF: University of California, San Francisco)H-Index: 99
view all 5 authors...
575 CitationsSource
#1Liang Ge (LMB: Laboratory of Molecular Biology)H-Index: 17
#2Jing Wang (LMB: Laboratory of Molecular Biology)H-Index: 11
Last.Bao-Liang Song (LMB: Laboratory of Molecular Biology)H-Index: 31
view all 8 authors...
212 CitationsSource
#2Marianne BennH-Index: 36
Last.Anne Tybjærg-HansenH-Index: 79
view all 4 authors...
1,420 CitationsSource
Cited By33
Newest
#1Genovefa KolovouH-Index: 31
#2Watts G.F. (UWA: University of Western Australia)H-Index: 83
Last.Børge G. Nordestgaard (Copenhagen University Hospital)H-Index: 119
view all 13 authors...
4 CitationsSource
#1Akihiro NakamuraH-Index: 13
#2Kenjiro SatoH-Index: 1
Last.Eiji NozakiH-Index: 8
view all 7 authors...
1 CitationsSource
#1Aspen R. Gutgsell (UNC: University of North Carolina at Chapel Hill)H-Index: 1
#2Swapnil V. Ghodge (UNC: University of North Carolina at Chapel Hill)H-Index: 5
Last.Saskia B. Neher (UNC: University of North Carolina at Chapel Hill)H-Index: 12
view all 4 authors...
2 CitationsSource
#1Huijin WuH-Index: 1
#2Hua ShangH-Index: 1
Last.Jing WuH-Index: 1
view all 3 authors...
6 CitationsSource
7 CitationsSource
#1Daisaku Masuda (Osaka University)H-Index: 17
#2Shizuya Yamashita (Osaka University)H-Index: 59
25 CitationsSource
#1Jean-Philippe Drouin-Chartier (Laval University)H-Index: 6
#2André J. Tremblay (Laval University)H-Index: 22
Last.Patrick Couture (Laval University)H-Index: 40
view all 6 authors...
4 CitationsSource
2 CitationsSource
6 CitationsSource
#1Seigo Sugiyama (Kumamoto University)H-Index: 49
#2Hideaki Jinnouchi (Kumamoto University)H-Index: 20
Last.Tomio Jinnouchi (Kumamoto University)H-Index: 8
view all 9 authors...
4 CitationsSource
View next paperEzetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia